Evaluation of N-terminal pro-B-type natriuretic peptide as a diagnostic marker of various stages of cardiomyopathy in Doberman Pinschers

American Journal of Veterinary Research

Volumn 72, Issue 5, 2011, Pages 642-649

  Wess, Gerhard ^a   Butz, Verena ^a   Mahling, Monia ^a   Hartmann, Katrin ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

AMBULATORY CARE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR SYSTEM EXAMINATION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DOG; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART VENTRICLE CONTRACTION; HOLTER MONITORING; MALE; NONHUMAN; PHYSICAL EXAMINATION; SENSITIVITY AND SPECIFICITY;

AGE DISTRIBUTION; ANIMAL HUSBANDRY; ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; CARDIOMYOPATHY, DILATED; DOG DISEASES; DOGS; ECHOCARDIOGRAPHY; FEMALE; MALE; NATRIURETIC PEPTIDE, BRAIN; PEDIGREE; PEPTIDE FRAGMENTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION;

ANIMALIA; CANIS FAMILIARIS;

EID: 79955768678     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.72.5.642     Document Type: Article

References (48)

1. O'Grady MR, O'Sullivan ML. Dilated cardiomyopathy: an update. Vet Clin North Am Small Anim Pract 2004;34:1187-1207.
2. Tidholm A, Haggstrom J, Borgarelli M, et al. Canine idiopathic dilated cardiomyopathy. Part I: aetiology, clinical characteristics, epidemiology and pathology. Vet J 2001;162:92-107.
3. Vollmar AC. The prevalence of cardiomyopathy in the Irish Wolfhound: a clinical study of 500 dogs. J Am Anim Hosp Assoc 2000;36:125-132.
4. Calvert CA, Meurs K. Cardiomyopathy in Doberman Pinschers. In: Bonagura JD, Twedt DC, eds. Kirk's current veterinary therapy XIV. St Louis: Saunders Elsivier, 2009;800-803.
5. Calvert CA, Brown J. Influence of antiarrhythmia therapy on survival times of 19 clinically healthy Doberman Pinschers with dilated cardiomyopathy that experienced syncope, ventricular tachycardia, and sudden death (1985-1998). J Am Anim Hosp Assoc 2004;40:24-28.
6. Calvert CA, Chapman WL Jr, Toal RL. Congestive cardiomyopathy in Doberman Pinscher dogs. J Am Vet Med Assoc 1982;181:598-602.
7. Calvert CA, Meurs K. CVT update: Doberman Pinscher occult cardiomyopathy. In: Bonagura JD, Kirk RW, eds. Kirk's current veterinary therapy XIII. Philadelphia: Saunders, 2000;756-760.
8. Wess G, Schulze A, Butz V, et al. Prevalence of dilated cardiomyopathy in Doberman Pinschers in various age groups. J Vet Intern Med 2010;24:533-538.
9. Calvert CA, Hall G, Jacobs G, et al. Clinical and pathologic findings in Doberman Pinschers with occult cardiomyopathy that died suddenly or developed congestive heart failure: 54 cases (1984-1991). J Am Vet Med Assoc 1997;210:505-511.
10. Calvert CA, Pickus CW, Jacobs GJ, et al. Signalment, survival, and prognostic factors in Doberman Pinschers with end-stage cardiomyopathy. J Vet Intern Med 1997;11:323-326.
11. Petric AD, Stabej P, Zemva A. Dilated cardiomyopathy in Doberman Pinschers: survival, causes of death and a pedigree review in a related line. J Vet Cardiol 2002;4:17-24.
12. Calvert CA, Jacobs G, Pickus CW, et al. Results of ambulatory electrocardiography in overtly healthy Doberman Pinschers with echocardiographic abnormalities. J Am Vet Med Assoc 2000;217:1328-1332.
13. Calvert CA, Jacobs GJ. Heart rate variability in Doberman Pinschers with and without echocardiographic evidence of dilated cardiomyopathy. Am J Vet Res 2000;61:506-511.
14. Calvert CA, Jacobs GJ, Kraus M. Possible ventricular late potentials in Doberman Pinschers with occult cardiomyopathy. J Am Vet Med Assoc 1998;213:235-239.
15. Calvert CA, Jacobs GJ, Kraus M, et al. Signal-averaged electrocardiograms in normal Doberman Pinschers. J Vet Intern Med 1998;12:355-364.
16. Calvert CA, Jacobs GJ, Smith DD, et al. Association between results of ambulatory electrocardiography and development of cardiomyopathy during long-term follow-up of Doberman Pinschers. J Am Vet Med Assoc 2000;216:34-39.
17. Wess G, Maurer J, Simak J, et al. Use of Simpson's method of disc to detect early echocardiographic changes in Doberman Pinschers with dilated cardiomyopathy. J Vet Intern Med 2010;24:1069-1076.
18. Hazlett MJ, Maxie MG, Allen DG, et al. A retrospective study of heart disease in Doberman Pinscher dogs. Can Vet J 1983;24:205-210.
19. O'Grady MR, O'Sullivan ML, Minors SL, et al. Efficacy of benazepril hydrochloride to delay the progression of occult dilated cardiomyopathy in Doberman Pinschers. J Vet Intern Med 2009;23:977-983.
20. Oyama MA, Sisson DD, Solter PF. Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-I concentrations. Am J Vet Res 2007;68:42-47.
21. Fine DM, DeClue AE, Reinero CR. Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease. J Am Vet Med Assoc 2008;232:1674-1679.
22. Oyama MA, Fox PR, Rush JE, et al. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity. J Am Vet Med Assoc 2008;232:1496-1503.
23. Piantedosi D, Cortese L, Di Loria A, et al. Plasma atrial natriuretic peptide (proANP 31-67), B-type natriuretic peptide (NtproBNP) and endothelin-1 (ET-1) concentrations in dogs with chronic degenerative valvular disease (CDVD). Vet Res Commun 2009;33 (suppl 1):197-200.
24. Prosek R, Sisson DD, Oyama MA, et al. Distinguishing cardiac and noncardiac dyspnea in 48 dogs using plasma atrial natriuretic factor, B-type natriuretic factor, endothelin, and cardiac troponin-I. J Vet Intern Med 2007;21:238-242.
25. Serres F, Pouchelon JL, Poujol L, et al. Plasma N-terminal pro- B-type natriuretic peptide concentration helps to predict survival in dogs with symptomatic degenerative mitral valve disease regardless of and in combination with the initial clinical status at admission. J Vet Cardiol 2009;11:103-121.
26. Takemura N, Toda N, Miyagawa Y, et al. Evaluation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations in dogs with mitral valve insufficiency. J Vet Med Sci 2009;71:925-929.
27. Tarnow I, Olsen LH, Kvart C, et al. Predictive value of natriuretic peptides in dogs with mitral valve disease. Vet J 2009;180:195-201.
28. Boswood A, Dukes-McEwan J, Loureiro J, et al. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease. J Small Anim Pract 2008;49:26-32.
29. O'Grady MR, Minors SL, O'Sullivan ML, et al. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy. J Vet Intern Med 2008;22:897-904.
30. Hothorn T, Bretz F, Westfall P. Simultaneous inference in general parametric models. Biom J 2008;50:346-363.
31. Akaike H. New look at statistical-model identification. IEEE Trans Automat Contr 1974;AC-19:716-723.
32. Kim H, Cho YK, Jun DH, et al. Prognostic implications of the NT-ProBNP level and left atrial size in non-ischemic dilated cardiomyopathy. Circ J 2008;72:1658-1665.
33. Bielecka-Dabrowa A, Wierzbicka M, Dabrowa M, et al. New methods in laboratory diagnostics of dilated cardiomyopathy. Cardiol J 2008;15:388-395.
34. Tigen K, Karaahmet T, Tanalp AC, et al. Value of clinical, electrocardiographic, echocardiographic and neurohumoral parameters in non-ischaemic dilated cardiomyopathy. Acta Cardiol 2008;63:207-212.
35. Fox PR, Oyama MA, Reynolds C, et al. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats. J Vet Cardiol 2009;11 (suppl 1):S51-S61.
36. Oyama MA, Rush JE, Rozanski EA, et al. Assessment of serum N-terminal pro-B-type natriuretic peptide concentration for differentiation of congestive heart failure from primary respiratory tract disease as the cause of respiratory signs in dogs. J Am Vet Med Assoc 2009;235:1319-1325.
37. Omland T, Hagve TA. Natriuretic peptides: physiologic and analytic considerations. Heart Fail Clin 2009;5:471-487.
38. Baumwart RD, Meurs KM. Assessment of plasma brain natriuretic peptide concentration in Boxers with arrhythmogenic right ventricular cardiomyopathy. Am J Vet Res 2005;66:2086-2089.
39. DeFrancesco TC, Rush JE, Rozanski EA, et al. Prospective clinical evaluation of an ELISA B-type natriuretic peptide assay in the diagnosis of congestive heart failure in dogs presenting with cough or dyspnea. J Vet Intern Med 2007;21:243-250.
40. Hori Y, Sano N, Kanai K, et al. Acute cardiac volume load-related changes in plasma atrial natriuretic peptide and N-terminal pro-B-type natriuretic peptide concentrations in healthy dogs. Vet J 2010;185:317-321.
41. Hori Y, Tsubaki M, Katou A, et al. Evaluation of NT-pro BNP and CT-ANP as markers of concentric hypertrophy in dogs with a model of compensated aortic stenosis. J Vet Intern Med 2008;22:1118-1123.
42. Scott PA, Barry J, Roberts PR, et al. Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis. Eur J Heart Fail 2009;11:958-966.
43. Galante O, Amit G, Zahger D, et al. B-type natruiretic peptide levels stratify the risk for arrhythmia among implantable cardioverter defibrillator patients. Clin Cardiol 2008;31:586-589.
44. Tada H, Ito S, Shinbo G, et al. Significance and utility of plasma brain natriuretic peptide concentrations in patients with idiopathic ventricular arrhythmias. Pacing Clin Electrophysiol 2006;29:1395-1403.
45. Pfister R, Diedrichs H, Larbig R, et al. NT-pro-BNP for differential diagnosis in patients with syncope. Int J Cardiol 2009;133:51-54.
46. Kellihan HB, Oyama MA, Reynolds CA, et al. Weekly variability of plasma and serum NT-proBNP measurements in normal dogs. J Vet Cardiol 2009;11 (suppl 1):S93-S97.
47. Calvert CA, Wall M. Results of ambulatory electrocardiography in overtly healthy Doberman Pinschers with equivocal echocardiographic evidence of dilated cardiomyopathy. J Am Vet Med Assoc 2001;219:782-784.
48. Raymond I, Groenning BA, Hildebrandt PR, et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003;89:745-751.